← Back to Search

Outpatient Treatment for Alcoholism

N/A
Waitlist Available
Led By Dongju Seo, PhD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 90 days
Awards & highlights

Study Summary

This trial will study how early trauma affects the brain and causes higher relapse rates in alcoholism.

Who is the study for?
This trial is for individuals with alcohol use disorder who have experienced early trauma, as measured by a specific questionnaire. Participants must have a BMI up to 35 due to MRI scanner limitations. It excludes those with significant medical conditions, other substance disorders (except caffeine and nicotine), certain psychiatric disorders, claustrophobia, metal implants, and peri- or post-menopausal women or those pregnant/lactating.Check my eligibility
What is being tested?
The study investigates the neurobiological responses in individuals with alcoholism affected by early trauma over an 8-week outpatient treatment period using advanced brain imaging techniques and stress hormone assessments to understand relapse risks.See study design
What are the potential side effects?
While not explicitly stated in the provided information, potential side effects may include discomfort from participating in MRI scans such as loud noises or confined spaces and possible psychological distress when discussing personal history of trauma.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alcohol relapse
Dynamic neural response
Stress hormone response
Secondary outcome measures
Alcohol use (frequency)
Alcohol Use Disorder

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Alcohol use disorderExperimental Treatment1 Intervention
Individuals with alcohol use disorder will receive an equivalent 8 week outpatient treatment.
Group II: ControlsActive Control1 Intervention
Control participants will undergo a baseline assessment without receiving any outpatient treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
8-week outpatient treatment
2019
N/A
~150

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
799 Previous Clinical Trials
1,362,363 Total Patients Enrolled
422 Trials studying Alcoholism
985,060 Patients Enrolled for Alcoholism
Yale UniversityLead Sponsor
1,847 Previous Clinical Trials
2,737,520 Total Patients Enrolled
83 Trials studying Alcoholism
10,081 Patients Enrolled for Alcoholism
Dongju Seo, PhDPrincipal InvestigatorYale University
1 Previous Clinical Trials
33 Total Patients Enrolled

Media Library

8-week outpatient treatment Clinical Trial Eligibility Overview. Trial Name: NCT04128228 — N/A
Alcoholism Research Study Groups: Alcohol use disorder, Controls
Alcoholism Clinical Trial 2023: 8-week outpatient treatment Highlights & Side Effects. Trial Name: NCT04128228 — N/A
8-week outpatient treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT04128228 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who has the capacity to partake in this clinical experiment?

"This clinical trial seeks to recruit 160 patients between 21 and 50 years old with wounds. Requirements for applicants include: Alcohol use disorder, Childhood Trauma Questionnaire scores that indicate either low or high early trauma levels, a BMI index of up to 35 (due to MRI scanner weight restraints), as well as an AUD."

Answered by AI

Are there currently any open slots for participation in this medical experiment?

"Affirmative. Information located on clinicaltrials.gov demonstrates that this examination is currently recruiting volunteers, having been first posted on October 3rd 2019 and recently updated on May 17th 2022. 160 individuals are anticipated to take part between 1 center of research."

Answered by AI

How many individuals have registered for participation in this research?

"Affirmative, according to clinicaltrials.gov the recruitment period for this medical trial began on October 3rd 2019 and was most recently updated on May 17th 2022. A total of 160 participants are necessary at one location."

Answered by AI

Does the age requirement for this trial extend beyond 80 years old?

"The age criteria for participants in this trial are 21 or older, but must be younger than 50 years of age."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Neurobiological Responses in Alcoholism and Early Trauma
2019. "Neurobiological Responses in Alcoholism and Early Trauma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04128228.
~27 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top